---
figid: PMC4691146__ijms-16-26203-g002
figlink: /pmc/articles/PMC4691146/figure/ijms-16-26203-f002/
number: Figure 2
caption: Processes affecting TOB1 levels and diverse mechanisms underlying TOB1 tumor
  suppression activity. (A) The level of TOB1 expression is affected by three different
  mechanisms, including LOH for TOB1 gene in the cancer genome, down-regulation of
  TOB1 mRNA expression by target microRNAs, and induction of TOB1 protein degradation
  by cues such as its phosphorylation. miR25 represses TOB1 mRNA expression by binding
  to its 3′-untranslated region (3′-UTR) directly. TOB1 phosphorylated by MAPKs or
  RPS6KA undergoes ubiquitination by the ubiquitin ligase, SKP2, resulting in its
  degradation through the proteasomal pathway; (B) TOB1, a tumor suppressor protein,
  inhibits cancer cell proliferation, invasion, and metastasis and leads to the induction
  of apoptosis. In addition to inhibiting the transcription of cell cycle-associated
  genes in the nucleus, TOB1 physically cooperates with tumor suppressors, SMAD4 or
  phosphatase, and tensin homolog-10 (PTEN), to produce a yet unknown signal for the
  degradation of AURKA or AKT, thereby indirectly regulating β-catenin level in the
  cytosol. Moreover, TOB1 directly interacts with β-catenin in the nucleus, leading
  to down-regulation of target genes of the TCF/β-catenin complex. TOB1 overexpression
  induces the reduction of BCL-2 and BCL-XL expression, increment of BAX expression,
  and caspase-3 activation.
pmcid: PMC4691146
papertitle: 'Transducer of ERBB2.1 (TOB1) as a Tumor Suppressor: A Mechanistic Perspective.'
reftext: Hun Seok Lee, et al. Int J Mol Sci. 2015 Dec;16(12):29815-29828.
pmc_ranked_result_index: '162018'
pathway_score: 0.9263604
filename: ijms-16-26203-g002.jpg
figtitle: Processes affecting TOB1 levels and diverse mechanisms underlying TOB1 tumor
  suppression activity
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4691146__ijms-16-26203-g002.html
  '@type': Dataset
  description: Processes affecting TOB1 levels and diverse mechanisms underlying TOB1
    tumor suppression activity. (A) The level of TOB1 expression is affected by three
    different mechanisms, including LOH for TOB1 gene in the cancer genome, down-regulation
    of TOB1 mRNA expression by target microRNAs, and induction of TOB1 protein degradation
    by cues such as its phosphorylation. miR25 represses TOB1 mRNA expression by binding
    to its 3′-untranslated region (3′-UTR) directly. TOB1 phosphorylated by MAPKs
    or RPS6KA undergoes ubiquitination by the ubiquitin ligase, SKP2, resulting in
    its degradation through the proteasomal pathway; (B) TOB1, a tumor suppressor
    protein, inhibits cancer cell proliferation, invasion, and metastasis and leads
    to the induction of apoptosis. In addition to inhibiting the transcription of
    cell cycle-associated genes in the nucleus, TOB1 physically cooperates with tumor
    suppressors, SMAD4 or phosphatase, and tensin homolog-10 (PTEN), to produce a
    yet unknown signal for the degradation of AURKA or AKT, thereby indirectly regulating
    β-catenin level in the cytosol. Moreover, TOB1 directly interacts with β-catenin
    in the nucleus, leading to down-regulation of target genes of the TCF/β-catenin
    complex. TOB1 overexpression induces the reduction of BCL-2 and BCL-XL expression,
    increment of BAX expression, and caspase-3 activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCND1
  - WNT3
  - WNT4
  - AKT2
  - AKT3
  - AKT1
  - WNT16
  - WNT5B
  - WNT1
  - WNT2
  - WNT3A
  - RPS6KA1
  - WNT5A
  - GSK3B
  - PTEN
  - WNT10A
  - APC
  - TOB1
  - PLAUR
  - BCL2L1
  - BAX
  - CTNNB1
  - BCL2
  - WNT7A
  - WNT7B
  - SMAD4
  - WNT6
  - AXIN1
  - AXIN2
  - WNT9B
  - AURKA
  - WNT2B
  - WNT8B
  - WNT9A
  - WNT8A
  - WNT11
  - WNT10B
  - Cancer
genes:
- word: CyclinD1,CDKS
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: RPS6KA1
  symbol: RPS6KA1
  source: hgnc_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: TOB1
  symbol: TOB1
  source: hgnc_symbol
  hgnc_symbol: TOB1
  entrez: '10140'
- word: UPAR,PAPRY
  symbol: UPAR
  source: hgnc_alias_symbol
  hgnc_symbol: PLAUR
  entrez: '5329'
- word: BCL-2,BCL-XL
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: BAX
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: BCL-2,BCL-XL
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: SMAD4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: AURKA
  symbol: AURKA
  source: hgnc_symbol
  hgnc_symbol: AURKA
  entrez: '6790'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: TOB
  symbol: TOB
  source: hgnc_alias_symbol
  hgnc_symbol: TOB1
  entrez: '10140'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
